More importantly, TdIF1 knockdown reduced tumor size in a nude mouse xenograft model of human NSCLC, which suggests that TdIF1 is also a potent regulator of NSCLC progression in vivo. The gene discussed is DNTTIP1; the disease is neoplasm.